SWASAM
IIT Jodhpur & AIIMS Jodhpur
SWASAM, a pioneering startup focused on non-invasive treatments for Deviated Nasal Septum (DNS), embarked on a transformative journey with GDC’s I-NCUBATE Program, and the results have been nothing short of revolutionary.
In the midst of their mission to alleviate the discomfort associated with DNS—a condition causing symptoms like sleep apnea, chronic headaches, sinusitis, blocked noses, and nosebleeds— SWASAM faced significant hurdles. Traditional treatments often involve invasive surgeries with high relapse rates and patient apprehension, which only compounded their challenge. SWASAM’s goal was to introduce a non-invasive solution that could address these issues more effectively and comfortably.
The I-NCUBATE Program played a crucial role in reshaping SWASAM’s strategy. The program’s structured approach provided invaluable business mentorship and insights, guiding SWASAM through critical phases of development and market understanding. Initially, the team struggled with assumptions about market readiness and patient acceptance. Through the program, they engaged deeply with a range of stakeholders, including ENT specialists, hospital management, and patients, which led to critical learnings.
Key insights revealed that patients were concerned about post-surgical recovery and discomfort, while surgeons faced challenges in convincing patients to undergo surgery. Additionally, the team discovered that a substantial portion of surgeries were covered by health insurance, yet a significant number of patients lacked coverage. This research underscored the need for a non-invasive alternative that could alleviate these concerns.
The I-NCUBATE Program’s mentorship enabled Swasam to refine their approach by invalidating initial assumptions and focusing on the most relevant customer segments. They identified early adopters, such as ENT specialists in private and super-specialty hospitals serving high-income patients, who were more likely to benefit from their innovative solution. This strategic pivot was instrumental in tailoring their product to meet specific market needs and improving patient care.
SWASAM’s experience with GDC’s I-NCUBATE Program highlights the transformative impact of targeted mentorship and strategic guidance. By providing insights into market dynamics and helping to refine their business model, the program has been pivotal in positioning SWASAM’s as a leader in non-invasive nasal care solutions. Their journey exemplifies how comprehensive support can turn promising innovations into impactful solutions, ultimately enhancing patient comfort and care.
